Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
1.975
-0.055 (-2.71%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Stereotaxis Market Cap

Stereotaxis has a market cap or net worth of $169.38 million as of April 25, 2025. Its market cap has decreased by -29.13% in one year.

Market Cap
169.38M
Enterprise Value
163.17M
1-Year Change
-29.13%
Ranking
Category
Stock Price
$1.98

Market Cap Chart

Since August 12, 2004, Stereotaxis's market cap has decreased from $183.10M to $169.38M, a decrease of -7.49%. That is a compound annual growth rate of -0.38%.

History

DateMarket Cap% Change
Apr 25, 2025169.40M-12.32%
Dec 31, 2024193.20M36.54%
Dec 29, 2023141.50M-8.65%
Dec 30, 2022154.90M-66.50%
Dec 31, 2021462.40M23.27%
Dec 31, 2020375.10M6.26%
Dec 31, 2019353.00M474.92%
Dec 31, 201861.40M237.36%
Dec 29, 201718.20M28.17%
Dec 30, 201614.20M-10.69%
Dec 31, 201515.90M-47.52%
Dec 31, 201430.30M-47.49%
Dec 31, 201357.70M215.30%
Dec 31, 201218.30M-55.90%
Dec 30, 201141.50M-76.45%
Dec 31, 2010176.20M-2.22%
Dec 31, 2009180.20M19.97%
Dec 31, 2008150.20M-63.64%
Dec 31, 2007413.10M27.11%
Dec 29, 2006325.00M49.56%
Dec 30, 2005217.30M991.96%
Dec 31, 200419.90M-89.13%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 772.65B
UnitedHealth Group 376.09B
Johnson & Johnson 367.43B
AbbVie 320.45B
Novo Nordisk 276.96B
Abbott Laboratories 220.95B
AstraZeneca 215.41B
Novartis AG 210.89B
Market Cap Rankings